col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Gastroenterology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―18 Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study Jin Ge, Mark J. Pletcher, Jennifer C. Lai, Jeremy R. Harper, Christopher G. Chute, Melissa A. Haendel
2 [GO] 2021―Jul―18 Exam 2: Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications
3 [GO] 2021―Jul―16 Measuring droplets expelled during endoscopy to investigate COVID-19 transmission risk Mark F. Coughlan, Mandeep S. Sawhney, Douglas K. Pleskow, Conor J. Sheil, Le Qiu, Lev T. Perelman, et al. (+9)
4 [GO] 2021―Jul―02 BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign Amir Ben-Tov, Tamar Banon, Gabriel Chodick, Revital Kariv, Amit Assa, Sivan Gazit
5 [GO] 2021―Jun―26 An unexpected thoracic finding in a COVID-19 patient Anna Calì, Rosa Federica La Fortezza, Pietro Fusaroli
6 [GO] 2021―Jun―23 Corneal Abrasions During Endoscopic Procedures in the COVID-19 Era Are a Preventable Phenomenon: A Quality Improvement Project Shida Haghighat, Frederick Soriano, Daniel A. Sussman, Jamie S. Barkin, Chunsu Jiang, Enrico O. Souto, et al. (+2)
7 [GO] 2021―Jun―23 Improving Colorectal Cancer Screening and Polyp Surveillance During the COVID-19 Pandemic Sobia Mujtaba, Deannys Batista, Raj Dalsania, Angela Ward, Heba Iskandar, Jennifer A. Christie
8 [GO] 2021―Jun―15 COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States. Yousaf Bashir Hadi, Shyam Thakkar, Sardar Momin Shah-Khan, William Hutson, Arif Sarwari, Shailendra Singh
9 [GO] 2021―Jun―15 Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2 Nadim Mahmud, Alexandra Weiss, Chinmay Trivedi, Yu-Xiao Yang, James Lewis, Nabeel Khan
10 [GO] 2021―May―25 Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications Nabeel Khan, Nadim Mahmud
11 [GO] 2021―May―21 AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update Shahnaz Sultan, Shazia M. Siddique, Siddarth Singh, Osama Altayar, Angela M. Caliendo, Perica Davitkov, et al. (+6)
12 [GO] 2021―May―18 Letter to the Editor: Characteristics of Liver Transplant Patients Admitted with COVID-19 Emad Mansoor, Seth S. Sclair, Gregory S. Cooper
13 [GO] 2021―May―18 COVID-19 Vaccination and IBD: Desired antibody responses, future directions, and a note of caution Irving Levine, Arun Swaminath, Isabel Roitman, Keith Sultan
14 [GO] 2021―May―13 Gut Microbiome Composition is Associated with COVID-19 Disease Severity Pooja Patel, Jatin Roper
15 [GO] 2021―May―11 Development of AGA’s policy agenda during the COVID-19 pandemic Simon Mathews, Yamini Natarajan, Anthony Sofia, Amit Patel, Dawn Francis, Sarah Streett, Shazia Siddique
16 [GO] 2021―May―10 Fr014 DISEASE BURDEN AND CARE-SEEKING BEHAVIOR FOR IBS-C PATIENTS IN THE UNITED STATES IN THE ERA OF COVID-19 Brian E. Lacy, Mousam Parekh, Douglas C. Taylor, Ceciel Rooker, Kate Burslem, Robert Morlock, Amy Morlock
17 [GO] 2021―May―10 Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19 Divya Jha, Ana S. Gonzalez-Reiche, Teresa Aydillo, Francesca Cossarini, Alexandra E. Livanos, Minami Tokuyama, et al. (+7)
18 [GO] 2021―May―10 Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19 Jon Alexander Torres, Cynthia W. Ko
19 [GO] 2021―May―10 Sa126 TROPISM OF SARS-COV-2 FOR BARRETT'S ESOPHAGUS MAY INCREASE SUSCEPTIBILITY TO DEVELOPING COVID-19 Ramon Jin, Jeffrey W. Brown, Alan Meeker, Qing K. Li, Peter Bayguinov, Jean S. Wang, et al. (+3)
20 [GO] 2021―May―10 Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19 Danial H. Shaikh, Haozhe Sun, Harish Patel, Dongmin Shin, Ahmed Baiomi, Shehriyar Mehershahi, et al. (+4)
21 [GO] 2021―May―10 Fr007 GASTROINTESTINAL MANIFESTATIONS OF COVID-19 ACROSS THE UNITED STATES: A MULTI-CENTER COHORT STUDY Ankur Patel, Troy Sanders, Sujay Alvencar, Alyssa Y. Choi, Jade Law, Janaki Shah, et al. (+20)
22 [GO] 2021―May―10 Fr503 FEAR OF COVID-19, ALONG WITH STRESS, ANXIETY, AND DEPRESSION, IS ASSOCIATED WITH BIOLOGIC USAGE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Rishabh Shah, Anoushka Dua, Bruce D. Naliboff, Priyam V. Tripathi, Robert Mocharla, Lisa Lin, et al. (+2)
23 [GO] 2021―May―10 Sa081 FEAR OF COVID-19 AMONG IBD PATIENTS ACCORDING TO EMPLOYMENT STATUS, EDUCATION AND RESIDENCE AND COMPARED TO OTHER GI CONDITIONS Bobby Lo, Manuel Barreiro-De-Acosta, Charles N. Bernstein, Johan Burisch, Nuno Ferreira, Richard Gearry, et al. (+4)
24 [GO] 2021―May―10 Sa114 PREVALENCE OF COVID-19 AMONG OUTPATIENTS PRESENTING FOR NON-URGENT ENDOSCOPY IN A LARGE HEALTHCARE NETWORK Camille Soroudi, Bao Sean Nguyen, Natalia Garcia Peñaloza, Liu Yang, Michael Rofail, Lynn Connolly, et al. (+3)
25 [GO] 2021―May―10 Sa052 VIRTUAL GASTROENTEROLOGY FELLOWSHIP RECRUITMENT DURING COVID-19 AND ITS IMPLICATIONS FOR THE FUTURE Nour Hamade, Indira Bhavsar-Burke, Claire Jansson-Knodell, Sachin B. Wani, Swati Patel, Adam C. Ehrlich, et al. (+4)
26 [GO] 2021―May―10 784 CLINICAL COURSE OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS WITH POSITIVE COVID-19 ANTIBODY TESTING AT A SINGLE, TERTIARY CARE CENTER Elizabeth A. Spencer, Eyal Klang, Michael T. Dolinger, Marla Dubinsky
27 [GO] 2021―May―10 Fr094 UTILITY OF COVID-19 ANTIBODY TESTING FOR PRE-ENDOSCOPY SCREENING Anika Noorali, Kenji Yoshida, Jeffery Stephens, Ryan A. Parrish, Shahriar Sedghi
28 [GO] 2021―May―10 Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION Sujay Alvencar, Michael Talanian, Abdallah Beano, Alexander Morrison, Padmavathi Srivoleti, Tahnee K. Sidhu, et al. (+7)
29 [GO] 2021―May―10 Fr009 THE RELATIONSHIP BETWEEN ADIPOSITY/SARCOPENIA AND DEATH AMONG PATIENTS WITH COVID-19 DIFFERS BASED ON THE PRESENCE OF GASTROINTESTINAL SYMPTOMS Yael R. Nobel, Steven Su, Michaela R. Anderson, Lyndon Luk, Gissette Soffer, Dympna Gallagher, Daniel E. Freedberg
30 [GO] 2021―May―10 Fr095 AN ANALYSIS OF GI AND NON-GI MANIFESTATIONS OF COVID-19 DURING THE FIRST WAVE OF THE PANDEMIC IN DARLINGTON, UNITED KINGDOM Anjan Dhar, Alexander Newman, Vikki Rand
31 [GO] 2021―May―10 Sa012 CORNEAL ABRASIONS DURING ENDOSCOPIC PROCEDURES IN THE COVID-19 ERA ARE A PREVENTABLE PHENOMENON: A QUALITY IMPROVEMENT PROJECT Shida Haghighat, Frederick B. Soriano, Daniel Sussman, Jamie S. Barkin, Chunsu Jiang, Enrico Souto, et al. (+2)
32 [GO] 2021―May―10 10 IMPACT OF CHRONIC LIVER DISEASE ON THE COVID-19 HOSPITAL ADMITTED PATIENTS Waseem Amjad, Ritu R. Singh, Adnan Malik, Faisal Jaura, Saad Saleem, Waqas Qureshi, Peter Ells
33 [GO] 2021―May―10 Fr104 ASSOCIATION OF GASTROINTESTINAL SYMPTOMS WITH OUTCOMES IN COVID-19 HOSPITALIZATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Deep Mehta, Nagaraj-Sanchitha Honganur, Zeba Murtaza, Richa Jaiswal, Aran Deol, Azka Zergham, et al. (+11)
34 [GO] 2021―May―10 Fr011 RELATIONSHIP BETWEEN GASTROINTESTINAL MANIFESTATIONS AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH COVID-19 IN A COMMUNITY BASED HOSPITAL SYSTEM Lynna Alnimer, Ali Zakaria, Christopher Hakim, Andrea R. Jamil, Kristina Ivezaj, Nina Rackerby, et al. (+3)
35 [GO] 2021―May―10 787 TIVURON PROJECT: AN INTERNATIONAL MULTICENTER PROSPECTIVE COHORT STUDY EVALUATING THE GASTROINTESTINAL SYMPTOMS AND COMPLICATIONS OF COVID-19 IN HOSPITALIZED PATIENTS Sergio A. Sánchez-Luna, Karina Cárdenas-Jaén, Alicia Vaillo-Rocamora, Micaela Riat Castro Zocchi, Daniel Useros Brañas, Laura Guberna Blanco, et al. (+32)
36 [GO] 2021―May―10 Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS John Sperger, Kushal S. Shah, Minxin Lu, Xian Zhang, Ryan C. Ungaro, Erica J. Brenner, et al. (+4)
37 [GO] 2021―May―10 Fr004 GASTROINTESTINAL MANIFESTATIONS OF COVID-19 IN ICU AND NON-ICU PATIENTS: A MULTI-CENTER COHORT STUDY Ankur Patel, Troy Sanders, Sujay Alvencar, Alyssa Y. Choi, Jade Law, Janaki Shah, et al. (+20)
38 [GO] 2021―May―10 Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS Shahab R. Khan, Babu P. Mohan, Saurabh Chandan, Suresh Ponnada, Marietta Iacucci, Subrata Ghosh, Udayakumar Navaneethan
39 [GO] 2021―May―10 Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS Gilaad Kaplan, Fox E. Underwood, Divine Tanyingoh, Manasi Agrawal, Ryan C. Ungaro, Erica J. Brenner, et al. (+10)
40 [GO] 2021―May―10 Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS Kartikeya Tripathi, Gala Godoy Brewer, Minh Thu Nguyen, Yuvaraj Singh, Mohamed Saleh Ismail, Jenny S. Sauk, et al. (+2)
41 [GO] 2021―May―10 435 INCIDENCE AND MORTALITY OF COVID-19 IN POST-LIVER TRANSPLANT PATIENTS IN A LARGE INTEGRATED HEALTHCARE SYSTEM Andy Tien, Megha S. Bhatnagar, Amandeep K. Sahota
42 [GO] 2021―May―10 Fr195 PERCEPTIONS OF COVID-19 IN THE EOSINOPHILIC ESOPHAGITIS POPULATION Shivani U. Thanawala, Claire Beveridge, Amanda B. Muir, Mary J. Strobel, Amity Westcott-Chavez, Kristle L. Lynch
43 [GO] 2021―May―10 Fr017 A MULTICENTER CASE SERIES OF COVID-19 INDUCED ACUTE PANCREATITIS AT 4 ACADEMIC CENTERS IN NEW YORK CITY Yasir Ali, Nihaal P. Karnik, Muhammad F. Ahmed, Mohammad S. Nawaz, Rajesh Veluvolu, Daria S. Yunina, et al. (+3)
44 [GO] 2021―May―10 7 A RETROSPECTIVE ANALYSIS OF COVID-19 INFECTED PATIENTS WITH ACUTE LIVER FAILURE IN A SAFETY NET HOSPITAL James R. Pellegrini, Bhanu Siva Kumar R. Sabbula, Daniel I. Meshoyrer, Jose R. Russe-Russe, Rezwan F. Munshi, Nourma Sajid, et al. (+4)
45 [GO] 2021―May―10 6 CIRRHOSIS IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 23,474 PATIENTS ACROSS 143 HOSPITALS Andrew W. Hwang, Rasiq Zackria, Eric H. Choi, Hyunju S. Heineke, Napatkamon Ayutyanont, Scott Kubomoto
46 [GO] 2021―May―10 Fr495 INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH SIGNIFICANTLY WORSENED CLINICAL OUTCOMES OF COVID-19 INFECTION IN A RETROSPECTIVE ANALYSIS OF 78,756 PATIENTS ACROSS 143 HOSPITALS Rasiq Zackria, Andrew W. Hwang, Scott Kubomoto, Hyunju S. Heineke, Napatkamon Ayutyanont, Eric H. Choi
47 [GO] 2021―May―10 8 PREDICTORS OF OUTCOMES OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Sunny Sandhu, Aalam Sohal, Sameeha Khalid, Dhuha Alhankawi, Ratnali Jain, Marina Roytman
48 [GO] 2021―May―10 Fr177 COVID-19 INFECTIONS IN THE EOSINOPHILIC GI DISEASE POPULATION ARE NOT SEVERE: INITIAL REPORT FROM A GLOBAL ONLINE REGISTRY Noam Zevit, Mima Chehade, John Leung, Evan S. Dellon
49 [GO] 2021―May―10 Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS Sara Ghoneim, Muhammad U. Butt, Sherif Saleh, Ronnie Fass
50 [GO] 2021―May―10 Fr010 THE DIFFERENTIAL IMPACT OF COVID-19 ON GASTROINTESTINAL ILLNESSES AND RATES OF HOSPITALIZATION: ANALYSIS FROM A REGIONAL INTEGRATED HEALTHCARE SYSTEM Tri M. Tran, Bechien U. Wu, Elizabeth Dong, Janet Lee, Mayra Martinez
51 [GO] 2021―May―10 Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS Ahmad Khan, Mohammad Bilal, Vincent R. Morrow, Frank Annie, Emad Mansoor, Gregory S. Cooper, et al. (+3)
52 [GO] 2021―May―10 Su316 INCREASED DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN HOSPITALIZED PATIENTS WITH ALCOHOL RELATED HEPATITIS AFTER THE COVID-19 OUTBREAK: A GLOBAL MULTI-CENTER PROPENSITY MATCHED ANALYSIS. Abhilash Perisetti, Randeep Kaur, Mary K. Rude, Jonathan Dranoff, Ragesh B. Thandassery
53 [GO] 2021―May―10 Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE Rajen Parekh, Xian Zhang, Ryan C. Ungaro, Erica J. Brenner, Manasi Agrawal, Jean Frederic Colombel, Michael Kappelman
54 [GO] 2021―May―10 Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES Manasi Agrawal, Erica J. Brenner, Joyce W. Mak, Xian Zhang, Gilaad Kaplan, Siew C. Ng, et al. (+3)
55 [GO] 2021―May―10 Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY Manasi Agrawal, Xian Zhang, Erica J. Brenner, Ryan C. Ungaro, Michael Kappelman, Jean Frederic Colombel
56 [GO] 2021―May―10 Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE Amanda Ricciuto, Christopher Lamb, Ellen Kuenzig, Anne M. Griffiths, Gilaad Kaplan, Gareth J. Walker, et al. (+3)
57 [GO] 2021―May―10 Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS Simcha Weissman, Muhammad Aziz, Wade M. Lee-Smith, Sameh Elias, Arun Swaminath, Joseph D. Feuerstein
58 [GO] 2021―May―10 670 COLONOSCOPY COMPLETION AFTER DIAGNOSIS OF RED FLAG SIGN OR SYMPTOM FOR COLORECTAL CANCER DURING THE COVID-19 PANDEMIC Joshua Demb, Ranier Bustamante, Ashley Earles, Lin Liu, Maria Elena Martinez, Samir Gupta
59 [GO] 2021―May―10 855 PATIENT-LED REMOTE INTRACAPILLARY PHARMACOKINETIC SAMPLING (FINGERPRICKS): VALIDATION AND ACCEPTABILITY FOR HOME THERAPEUTIC DRUG MONITORING IN PATIENTS WITH IBD IN THE COVID-19 PANDEMIC Desmond Chee, Rachel Nice, Benjamin Hamilton, Edward Jones, Sarah Hawkins, Clare Redstone, et al. (+6)
60 [GO] 2021―May―10 Fr091 WHY AREN'T WE USING TELEMEDICINE MORE? A COMPARISON OF TELEMEDICINE USAGE ACROSS GI AND CANCER CLINICS DURING THE COVID-19 PANDEMIC Shajan Peter, Kirk Russ, Nipun B. Reddy, Eric L. Wallace, Kelley Williams, Douglas R. Morgan, et al. (+2)
61 [GO] 2021―May―10 Fr096 PERCEPTIONS OF TELEMEDICINE OFFICE VISITS DURING THE COVID-19 PANDEMIC Ethan Foliente, Aslam Godil, Glenn Gookin, Alexander Chang, Lauren Chang, Madeline Evans, et al. (+4)
62 [GO] 2021―May―10 Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC. Lily Olayinka, Gilaad Kaplan, Christopher Ma, Leanne Reeb, Remo Panaccione, Karen I. Kroeker
63 [GO] 2021―May―10 Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC. Andrea Costantino, Luca Elli, Daniele Noviello, Leda Roncoroni, Francesco Simone Conforti, Nicoletta Nandi, et al. (+4)
64 [GO] 2021―May―10 Sa001 OPTIMAL USE OF LIMITED COLONOSCOPY CAPACITY IN A FIT-BASED CRC SCREENING PROGRAM DURING COVID-19 PANDEMIC Lucie De Jonge, Hilliene J. van de Schootbrugge-Vandermeer, Emilie C. Breekveldt, Manon Spaander, Anneke Van Vuuren, Folkert J. Van Kemenade, et al. (+5)
65 [GO] 2021―May―10 Sa011 IMPROVING COLORECTAL CANCER SCREENING AND POLYP SURVEILLANCE DURING THE COVID-19 PANDEMIC Sobia Mujtaba, Deannys Batista, Raj Dalsania, Angela Ward, Heba Iskandar, Jennifer A. Christie
66 [GO] 2021―May―10 Sa056 VIRAL KINETICS OF A HASHTAG: SOCIAL MEDIA ENGAGEMENT OF MAJOR GASTROENTEROLOGY AND HEPATOLOGY CONFERENCES DURING THE COVID-19 PANDEMIC Bilal A. Asif, Christopher Koh
67 [GO] 2021―May―10 Sa116 A SAFETY ASSESSMENT OF THE RE-OPENING OF AN ACADEMIC MEDICAL CENTER OUTPATIENT ENDOSCOPY UNIT DURING THE COVID-19 PANDEMIC Scott Manski, Christopher Schmoyer, Alice Pang, Joshua Lieberman, Micaela Gernhardt, Neveda Murugesan, et al. (+4)
68 [GO] 2021―May―10 Sa170 CIMETIDINE USE IN U.S.: EFFECTS OF FDA WITHDRAWAL OF RANITIDINE AND COVID-19 PANDEMIC David H. Balaban, Sherrie McNamara, Deborah J. Galt
69 [GO] 2021―May―10 Sa573 QUALITY OF LIFE (QOL), COPING, AND RESILIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING THE COVID-19 PANDEMIC Margaret C. Fink, Madison L. Simons, Tiffany Taft
70 [GO] 2021―May―10 Su390 OUTCOMES OF AN UNGUIDED, WEB-BASED COGNITIVE BEHAVIORAL THERAPY PROGRAM FOR IRRITABLE BOWEL SYNDROME DELIVERED DURING THE COVID-19 PANDEMIC Jocelynn T. Owusu, Alice Sibelli, Walter E. Sipe, Megan Oser
71 [GO] 2021―May―10 Su364 PILL OR PROCEDURE? UNDERSTANDING PATIENT PREFERENCES REGARDING BETA-BLOCKERS AS AN ALTERNATIVE TO ENDOSCOPIC VARICEAL SCREENING DURING THE COVID-19 PANDEMIC Zheng Che, Jeremy Louissaint, Ihab Kassab, Elliot B. Tapper
72 [GO] 2021―May―10 Sa077 DOES THE LOCKDOWN DUE TO COVID-19 PANDEMIC AFFECT THE LIFESTYLE AND DISEASE ACTIVITY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE? Shuhei Hosomi, Yu Nishida, Koji Fujimoto, Rieko Nakata, Yuji Nadatani, Shusei Fukunaga, et al. (+8)
73 [GO] 2021―May―10 Sa003 COVID-19 PANDEMIC AND REDUCTION OF COLORECTAL CANCER SCREENING RELATED PROCEDURES IN THE CZECH REPUBLIC Stepan Suchanek, Ondrej Ngo, Grega Tomas, Gabriela Vojtechova, Ondrej Majek, Miroslav Zavoral
74 [GO] 2021―May―10 314 INEQUITY EXISTS IN TELEMEDICINE USE DURING THE COVID-19 PANDEMIC FOR GASTROINTESTINAL SURGERY PATIENTS IN THE DEEP SOUTH Connie Shao, Chandler McLeod, Sushanth Reddy, Lauren Theiss, Isabel Marques, Karin M. Hardiman, et al. (+6)
75 [GO] 2021―May―10 Fr499 RATES OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES INFECTION DURING THE COVID-19 PANDEMIC IN A TERTIARY HEALTHCARE SETTING Karl Hazel, Mairead Skally, Emily Glynn, Margaret Foley, Karen Burns, Aoibhlinn M. O'Toole, et al. (+2)
76 [GO] 2021―May―10 Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE Monica Dahiya, Lily Olayinka, Gilaad Kaplan, Leanne Reeb, Christopher Ma, Remo Panaccione, Karen I. Kroeker
77 [GO] 2021―May―10 Fr013 COVID-19 PANDEMIC LOWERED RATES OF INPATIENT GASTROENTEROLOGY CONSULTS AND ENDOSCOPIC PROCEDURES BUT DID NOT CHANGE RATES OF GASTROINTESTINAL BLEEDING OR RELATED INTERVENTIONS Marlana J. Radcliffe, Kamal Baig, Tiffany Lambrou, Gregory Piech, Zachary Jurkowski, Neil Nadpara, et al. (+2)
78 [GO] 2021―May―10 Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY Theodore R. Levin, Christopher D. Jensen, Amy R. Marks, Wei K. Zhao, Kevin T. Kao, Dan Li, et al. (+11)
79 [GO] 2021―May―10 Fr002 EFFECT OF THE COVID-19 PANDEMIC ON ACUTE GASTROINTESTINAL BLEEDING Sumana Reddy, Beyla Patel, Luke Baldelli, Rajiv Majithia, Michael Dougherty
80 [GO] 2021―May―10 786 IMPACT OF THE COVID-19 PANDEMIC ON COLORECTAL CANCER INCIDENCE AND DEATH IN THE UNITED STATES Ravi Sharaf, Soham Sinha, Zixuan Li, Ariel Bar-Mashiah, Uri Ladabaum
81 [GO] 2021―May―10 Fr102 ASSESSING THE REPERCUSSIONS OF COVID-19 PANDEMIC ON DISEASE MANAGEMENT, PHYSICAL, AND EMOTIONAL WELL-BEING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Mohammed El-Dallal, Ariana Saroufim, Hannah Systrom, Sarah Ballou, Adam S. Cheifetz, Joseph D. Feuerstein
82 [GO] 2021―May―10 Fr090 IMPACT OF THE COVID-19 PANDEMIC ON ENDOSCOPY CANCELLATIONS Connie W. Wang, Yao-Wen Cheng, Richard Mclean, Stephanie Kim, Jonathan P. Terdiman, Priya Kathpalia, Kendall Beck
83 [GO] 2021―May―10 Su324 THE IMPACT OF THE COVID-19 PANDEMIC ON LIVER BIOMARKERS AND QUALITY OF LIFE IN PATIENTS WITH NAFLD Lindsay M. Clarke, Adam Buckholz, Julia Speiser, Mallory Ianelli, Carolyn Newberry, Reem Z. Sharaiha, et al. (+2)
84 [GO] 2021―May―10 Fr103 STRATIFYING THE IMPACT OF COVID-19 PANDEMIC ON THE EMOTIONAL AND PHYSICAL WELL-BEING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Mohammed El-Dallal, Ariana Saroufim, Hannah Systrom, Sarah Ballou, Adam S. Cheifetz, Joseph D. Feuerstein
85 [GO] 2021―May―10 Sa110 IMPACT OF COVID-19 PANDEMIC ON THE MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS ADMITTED WITH UPPER GASTROINTESTINAL BLEEDING Ekawat Manomaiwong, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya, Uayporn Kaosombatwattana
86 [GO] 2021―May―10 Fr092 INCREASED BURDEN OF SWALLOWING DISORDERS DURING THE COVID-19 PANDEMIC: A HOSPITAL SYSTEM-WIDE AUDIT Waihong Chung, May Min, Savan Kothadia, Firrah Saeed, James Scharfen, Fadlallah Habr
87 [GO] 2021―May―10 436 INCREASED BURDEN OF ALCOHOL-RELATED GASTROINTESTINAL AND LIVER DISEASES DURING THE COVID-19 PANDEMIC: A HOSPITAL SYSTEM-WIDE AUDIT Waihong Chung, May Min, Savan Kothadia, Firrah Saeed, James Scharfen, Fadlallah Habr
88 [GO] 2021―May―10 Su254 REDUCED ENDOSCOPY UTILIZATION FOR UPPER GASTROINTESTINAL BLEEDING DURING COVID-19 PANDEMIC: A MULTICENTER RESEARCH NETWORK STUDY Hemant Goyal, Abhilash Perisetti, Mahesh Gajendran, Saurabh Chandan, Jiannis Anastasiou, Aman Ali, et al. (+3)
89 [GO] 2021―May―10 Sa101 INCREASING THE LOW-RISK THRESHOLD FOR PATIENTS WITH UPPER GASTROINTESTINAL BLEEDING DURING THE COVID-19 PANDEMIC: A PROSPECTIVE, MULTICENTRE, FEASIBILITY STUDY Philip Dunne, Victoria Livie, Aaron P. McGowan, Wilson W. Siu, Sardar Chaudhary, Allan J. Morris, et al. (+5)
90 [GO] 2021―May―10 Fr553 PATIENT PERCEPTIONS ON TRANSITION FROM CLINIC-BASED INFUSIONS TO HOME-BASED INFUSIONS FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: A QUALITATIVE QUALITY IMPROVEMENT STUDY Janson Jacob, Daniel Aintabi, Melissa DeJonckheere, John I. Allen, David Irani, A. Mark Fendrick, et al. (+3)
91 [GO] 2021―May―10 Fr304 HYPERLIPASEMIA DOES NOT CONFER WORSE CLINICAL OUTCOMES IN A RETROSPECTIVE COHORT OF NOVEL CORONAVIRUS (COVID-19) PATIENTS Zaid Imam, Inayat Gill, Bana Antonios, Andrew Aneese, Guarav Kakked, Faisal Kamal, et al. (+2)
92 [GO] 2021―May―10 Fr578 ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS. Ana A. Pisarevsky, Fabiana Lopez Mingorance, Patrica Vega, Juan P. Stefanolo, Julieta A. Repetti, Guillermina Ludueña, et al. (+11)
93 [GO] 2021―May―10 Fr577 ORAL BACTERIOTHERAPY IN THE MANAGEMENTE OF FATIGUE IN COVID-19 PATIENTS Massimiliano Marazzato, Giancarlo Ceccarelli, Luigi Celani, Eugenio Nelson Cavallari, PAOLO VASSALINI, Gabriella D'Ettorre
94 [GO] 2021―May―10 Su321 DEGREE AND PATTERN OF ELEVATED HEPATOBILIARY ENZYMES ARE PROGNOSTIC OF SEVERE CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS Jason Wagner, Andrew Dupont, Brooks D. Cash, Ahmad Farooq
95 [GO] 2021―May―10 Fr008 THE CLINICAL SIGNIFICANCE OF ELEVATED LIPASE LEVELS IN COVID-19 PATIENTS - A LARGE RETROSPECTIVE COHORT STUDY Suresh Kumar Nayudu, Jasbir Makker, Haozhe Sun, Dongmin Shin, Sharon Renner, Syeda H. Salman, et al. (+4)
96 [GO] 2021―May―10 Fr097 CLINICAL CHARACTERISTICS, GASTROINTESTINAL MANIFESTATIONS AND OUTCOMES OF COVID-19 PATIENTS AMONG MINORITIES IN THE USA Hassan Ashktorab, Antonio Pizuorno, Maryam Mehdipour Dalivand, Folake O. Adeleye, Gholamreza Oskrochi, Angesom Kibreab, et al. (+20)
97 [GO] 2021―May―10 Su320 A RETROSPECTIVE ANALYSIS OF OUTCOMES AMONGST COVID-19 PATIENTS WITH ACUTE HEPATITIS RECEIVING N-ACETYLCYSTEINE THERAPY IN A SAFETY NET HOSPITAL James R. Pellegrini, Rezwan F. Munshi, Jose R. Russe-Russe, Lorin Berman, Reshma George, Swarna Veeramani, et al. (+4)
98 [GO] 2021―May―10 Su319 KEY PRO-INFLAMMATORY/INJURY FEATURES OF COVID-19 PATIENTS WITH ALCOHOL USE Cristian D. Rios, Sally Condon, Michael Eiswerth, Sirmad Chaudhary, Maiying kong, Huirong Hu, et al. (+3)
99 [GO] 2021―May―10 Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING. Emmanuel O. Attah, Emily S. Smith, Tracey Martin, Sunena Tewani, Kaveh Hajifathalian, Reem Z. Sharaiha, et al. (+2)
100 [GO] 2021―May―10 Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS Alexandra E. Livanos, Francesca Cossarini, Tommaso Parigi, Katie A. Dunleavy, Rebekah E. Dixon, Divya Jha, et al. (+10)
101 [GO] 2021―May―10 Fr402 MELD-NA SCORE VERSUS SOFA SCORE AND APACHE II SCORE AS EARLY PREDICTORS OF MORTALITY IN COVID-19 PATIENTS WITH LIVER INVOLVEMENT Sandra R. Gomez, Eric Lam, Luis Gonzalez Mosquera, Joshua Fogel, Paul Mustacchia
102 [GO] 2021―May―10 Fr093 COVID-19 PEDIATRIC PATIENTS IN THE UNITED STATES; AFRICAN AMERICAN AND HISPANIC AMONG MOST HOSPITALIZED PATIENTS WITH PERSISTENT GI MANIFESTATIONS Yusuf Ashktorab, Anas Brim, Antonio Pizuorno, Sahar Nikdel, Vijay Gayam, Hassan Brim
103 [GO] 2021―May―10 Su323 THE PATTERNS OF LIVER INJURY IN COVID-19 POSITIVE PREGNANT FEMALES: A CASE SERIES Sneha Raju, Sarika Ziemann, Kavya Kelagere Mayigegowda, Moises I. Nevah, Preethi M. Reddy, Victor I. Machicao, Tugrul Purnak
104 [GO] 2021―May―10 Fr579 THE GUT MICROBIOME OF COVID-19 RECOVERED PATIENTS RETURNS TO UNINFECTED STATUS IN A MINORITY-DOMINATED UNITED STATES COHORT Rachel C. Newsome, Raad Z. Gharaibeh, Josee Gauthier, Maria C. Hernandez, George E. Abraham, Tanya Robinson, et al. (+12)
105 [GO] 2021―May―10 783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY Lucie De Jonge, Joachim Worthington, Francine v. Wifferen, Nicolas Iragorri, Elisabeth F. Peterse, Jie-Bin Lew, et al. (+7)
106 [GO] 2021―May―10 769 COVID-19’S IMPACT ON CANCER CARE: INCREASED EMOTIONAL STRESS IN PATIENTS AND HIGH RISK OF PROVIDER BURNOUT Omid Salehi, Sylvia V. Alarcon, Eduardo A. Vega, Onur C. Kutlu, Olga Kozyreva, Jennifer Chan, et al. (+3)
107 [GO] 2021―May―10 Fr134 SARS-COV-2 INDUCES EPITHYELIAL-NEURONAL CROSSTALK STIMULATING VASOACTIVE INTESTINAL PEPTIDE RELEASE AS A POTENTIAL MECHANISM OF COVID-19-ASSOCIATED DIARRHEA Peijian He, Philip Tedbury, Adam D. Gracz, Simon M. Mwangi, Ge Li, Didier Merlin, et al. (+2)
108 [GO] 2021―May―10 Fr502 INFLAMMATORY BOWEL DISEASE AND COVID-19: A LARGE INTEGRATED HEALTHCARE EXPERIENCE Vartan C. Tashjian, Angeline Luong, Libby Stein, Jonathan I. Chang, Bechien U. Wu, Marianne Fahmy
109 [GO] 2021―May―10 Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY Massimiliano Marazzato, Giancarlo Ceccarelli, Gabriella D'Ettorre, LETIZIA SANTINELLI, Claudia Pinacchio, Luigi Celani, Eugenio Nelson Cavallari
110 [GO] 2021―May―10 Su318 PATTERNS OF LIVER TRANSPLANTATION EVALUATIONS FOR HOSPITALIZED ADULTS WITH ACUTE ALCOHOLIC HEPATITIS DURING COVID-19: A SINGLE CENTER STUDY Saroja Bangaru, Jihane N. Benhammou, Jung Yum, Tien S. Dong, Arpan A. Patel, Gina Choi, Sammy Saab
111 [GO] 2021―May―10 Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY Ryan C. Ungaro, Manasi Agrawal, Erica J. Brenner, Xian Zhang, Jean Frederic Colombel, Michael Kappelman, Walter Reinisch
112 [GO] 2021―May―10 Su089 SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IBS DURING COVID-19: INITIAL FINDINGS FROM A CROSS-SECTIONAL SURVEY Christine Yu, Stephanie Tovar, Ariadna Padilla, Dana Pounds, Jiaxiao M. Shi, Bechien U. Wu
113 [GO] 2021―May―10 Fr228 AN INTERNATIONAL REPORTING REGISTRY OF PATIENTS WITH CELIAC DISEASE AND COVID-19: INITIAL RESULTS FROM SECURE-CELIAC Eugenia Uche-Anya, Steffen Husby, Gilaad Kaplan, Fox E. Underwood, Peter H.R. Green, Benjamin Lebwohl
114 [GO] 2021―May―10 Su083 PERSISTENCE OF GASTROINTESTINAL SYMPTOMS AFTER HOSPITALIZATION FOR COVID-19: PREVALENCE AND RISK FACTORS John W. Blackett, Daniela Jodorkovsky, Daniel E. Freedberg
115 [GO] 2021―May―10 Su326 IS TRANSAMINITIS AN INDEPENDENT RISK FACTOR FOR ALL-CAUSE MORTALITY IN COVID-19? Mohsin Mughal, Ikwinder P. Kaur, Mili kakadia, Reem Alhashemi, Hamzah A. Qudah, Sarah Azad, et al. (+5)
116 [GO] 2021―May―10 9 ELEVATED LIVER ENZYMES PORTENDS A HIGHER RATE OF COMPLICATIONS AND DEATH IN ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) Emily E. Currier, Mohamad A. Dabaja, Syed-Mohammed Jafri
117 [GO] 2021―May―10 Su317 CORONAVIRUS DISEASE 2019 AND LIVER INJURY: A RETROSPECTIVE ANALYSIS OF HOSPITALIZED PATIENTS IN NEW YORK CITY Joshua M. Bender, Howard J. Worman
118 [GO] 2021―May―10 Fr508 TRANSITION TO HOME INFUSION FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING CORONAVIRUS DISEASE 2019 PANDEMIC: PATIENT SATISFACTION SURVEY Ravi Teja Pasam, Salini Samyuktha Gadupudi, Adel Farhoud, Laurie B. Grossberg, Randall Pellish, Khadija Chaudrey
119 [GO] 2021―May―10 Sa571 EVALUATION OF MENTAL STATE AND CLINICAL SYMPTOMS OF CORONAVIRUS PANDEMIC IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Mizuki Tani, Shinichiro Shinzaki, Akiko Asakura, Taku Tashiro, Takahiro Amano, Yuriko Otake, et al. (+7)
120 [GO] 2021―May―10 Fr446 INCIDENCE OF “NEW-ONSET” CONSTIPATION AND ASSOCIATED FACTORS DURING LOCKDOWN DUE TO THE CORONAVIRUS-19 PANDEMIC. Jose Maria Remes-Troche, Enrique Coss-Adame, Mercedes Amieva-Balmori, Jose Antonio Velarde Ruiz Velasco, Paulo C. Gomez-Castaños, Ricardo Flores Rendon, et al. (+6)
121 [GO] 2021―May―10 11 TRENDS IN ALCOHOL RELATED LIVER DISEASE DURING THE SARS-COV 2 PANDEMIC: REAL-TIME ANALYSIS OF SYSTEMWIDE DATA TRENDS USING EPIC SLICERDICER™. Travis Roark, Julio Gutierrez, Catherine T. Frenette
122 [GO] 2021―May―10 Fr135 DEVELOPING AN ORGANOID MODEL TO UNDERSTAND THE BAT GASTROINTESTINAL EPITHELIAL RESPONSE TO THE SEVER ACUTE RESPIRATORY CORONA VIRUS-2 (SARS-COV-2) Marziah Hashimi, Thomas A. Sebrell, Katrina Lyon, Barkan Sidar, Tony Schountz, James N. Wilking, Diane Bimczok
123 [GO] 2021―May―10 Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2 Christopher R. Lindholm, Erin Spengler, Xiaofei Zhang, Kimberly E. Daniel
124 [GO] 2021―May―10 Fr003 TRUE PREVALENCE OF SARS-COV-2 INDUCED DIARRHEA AMONG YOUNG AND OLDER ADULTS: A MULTICENTER STUDY Abhilash Perisetti, Hemant Goyal, Mahesh Gajendran, Saurabh Chandan, Ritu R. Singh, Ragesh B. Thandassery, et al. (+4)
125 [GO] 2021―May―10 782 PERSISTENT GASTROINTESTINAL SYMPTOMS AND CHRONIC FATIGUE AFTER SARS-COV-2 INFECTION. Daniele Noviello, Andrea Costantino, Antonio Muscatello, Dario Consonni, Maurizio Vecchi, Guido Basilisco
126 [GO] 2021―May―10 Su102 DIFFERENCES IN INTESTINAL EPITHELIAL GENE EXPRESSION MODULATES SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS David M. Alvarado, Maria Gomez Castro, Naomi Sonnek, Xueyang Cui, Siyuan Ding, Matthew A. Ciorba
127 [GO] 2021―May―10 731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS Joelynn Dailey, Jeffrey S. Hyams, Dena Hopkins, Kristen Grandonico, Michael Brimacombe, Blaine Lapin, et al. (+8)
128 [GO] 2021―May―10 Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE Anna L. Silverman, Douglas Arneson, Saroja Bangaru, Bing Zhang, Diane Rodden, Sonya Dasharathy, et al. (+5)
129 [GO] 2021―May―10 785 SARS-COV-2 INFECTS ENTEROCYTES IN VIVO AND CAN PERSIST UP TO 7 MONTHS FOLLOWING RESOLUTION OF SYMPTOMS Minami Tokuyama, Mark S. Ladinsky, Divya Jha, Francesca Cossarini, Alexandra E. Livanos, Jason Reidy, et al. (+4)
130 [GO] 2021―May―10 Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB Marianne Spalinger, Rong Hai, Jiang Li, Tara M. Nordgren, Michel L Tremblay, Lars Eckmann, et al. (+5)
131 [GO] 2021―May―10 Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH Sabine Hazan, Jordan Daniels
132 [GO] 2021―May―10 Fr136 CENTER-BASED EXPERIENCES IMPLEMENTING STRATEGIES TO REDUCE RISK OF HORIZONTAL TRANSMISSION OF SARS-COV-2: POTENTIAL FOR COMPROMISE OF NEONATAL MICROBIOME ASSEMBLAGE Joann Romano-Keeler, Dana Fiszbein, Jilei Zhang, Joseph Horowitz, Karen Hayani, Irina Buhimschi, et al. (+7)
133 [GO] 2021―May―10 Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE Luca Elli, Federica Facciotti, Vincenza Lombardo, David Sanders, Valentina Vaira, Donatella Barisani, et al. (+7)
134 [GO] 2021―May―10 Sa096 NATIONAL TRENDS OF GASTROINTESTINAL BLEED RELATED DISEASES AND PROCEDURES DURING THE COVID PANDEMIC Haig Pakhchanian, Rahul Raiker, Khushnuma Alam, Shailendra Singh, Shyam Thakkar
135 [GO] 2021―May―10 Su392 AN INTERNATIONAL STUDY ON WELL-BEING OF PATIENTS WITH GASTROINTESTINAL DISORDERS DURING THE COVID19 PANDEMIC Miranda A. Van Tilburg, Antonina Mikocka-Walus, Andreas Stengel, Inês A. Trindade, Gabriele Moser, Anna Mokrowiecka, et al. (+9)
136 [GO] 2021―May―10 Su399 HEALTH PERCEPTIONS AND UTILIZATION IN NEUROGASTROENTEROLOGY CLINICS DURING THE COVID PANDEMIC Rachel Rosen, Alexandra Cohen, Courtney DiFilippo, Madeline Kane, Samuel Nurko
137 [GO] 2021―May―10 Su093 GUT-BRAIN AXIS AND IRRITABLE BOWEL SYNDROME DURING SARS COV-2 PANDEMIC. A SURVEY BASED STUDY. Maria Piskorz, Juan P. Stefanolo, Agustin Ibañez, Eugenia Hesse, Gladys Bravo Velez, Adriana Tevez, et al. (+5)
138 [GO] 2021―May―10 788 INCREASE IN ALCOHOLIC HEPATITIS CASES DURING COVID PANDEMIC IN THE US Geethu G. Nair, M. Mazen Jamal, Napatkamon Ayutyanont, Hyunju S. Heineke, Scott Kubomoto
139 [GO] 2021―May―10 Fr072 RISK OF HEALTHCARE-ASSOCIATED CLOSTRIDIOIDES DIFFICILE INFECTION DURING PANDEMIC PREPARATION: A RETROSPECTIVE COHORT STUDY Lauren Suarez, Judith Kim, Daniel E. Freedberg, Benjamin Lebwohl
140 [GO] 2021―May―10 110 WORKING SMARTER NOT HARDER: USING SIMULATION TO EVALUATE EVIDENCE-BASED STRATEGIES TO OFFLOAD COLONOSCOPY BACKLOGS RELATED TO COVID-19 Adam VanDeusen, Sameer D. Saini, Eve A. Kerr, Amy Cohn, Timothy Hofer, Andrew Gawron, et al. (+2)
141 [GO] 2021―May―10 18 COVID-19 AND THE GUT IN HUMAN OBESITY: OVEREXPRESSION OF SARS-COV-2 RECEPTORS REVEALED BY DEEP SINGLE CELL RNA-SEQ Alison Mcrae, Maria Laura Ricardo Silgado, Gerardo Calderon, Daniel Gonzalez Izundegui, Cadman L. Leggett, Vernadette Simon, et al. (+6)
142 [GO] 2021―May―10 114 TELEMEDICINE IN THE COVID-19 ERA: IMPACT ON DISPARITIES IN ACCESS TO AMBULATORY CARE Nicolette J. Rodriguez, Noreen C. Okwara, Lin Shen, Kunal Jajoo, Walter W. Chan
143 [GO] 2021―May―10 112 IMPACT OF COVID-19 INFECTION AMONG PATIENTS WITH PRE-EXISTING GASTROINTESTINAL CANCERS IN THE UNITED STATES: A MULTICENTER RESEARCH NETWORK STUDY. Ahmad Khan, Mohammad Bilal, Vincent R. Morrow, Frank Annie, Emad Mansoor, Gregory S. Cooper, et al. (+3)
144 [GO] 2021―May―10 111 RISK OF COVID-19 INFECTION TO BOTH PATIENTS AND ENDOSCOPY UNIT STAFF FOLLOWING ENDOSCOPY: A SINGLE-CENTER PROSPECTIVE COHORT STUDY Sanad M. Dawod, Qais M. Dawod, Kaveh Hajifathalian, Kartik Sampath, Srihari Mahadev, David L. Carr-Locke, Reem Z. Sharaiha
145 [GO] 2021―May―10 252 PREDNISONE, BUT NOT BIOLOGICS OR IMMUNOMODULATORS ARE ASSOCIATED WITH SEVERE COVID-19 OUTCOMES: A COMMUNITY BASED STUDY Fernando Velayos, Jennifer R. Dusendang, Julie A. Schmittdiel
146 [GO] 2021―May―10 113 COVID-19 PANDEMIC INCREASED HEALTHCARE UTILIZATION AMONG PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS John Mark Gubatan, Thomas Zikos, John Wu, Estelle Spear, Andres C. Gottfried, Laren S. Becker, et al. (+2)
147 [GO] 2021―May―10 426 DETECTION OF SARS-COV-2 IN THE GASTROINTESTINAL TRACT AMONG PATIENTS WITH NEGATIVE NASOPHARYNGEAL COVID-19 TESTING PRIOR TO ENDOSCOPY: A PROSPECTIVE STUDY Dennis Yang, Yaseen B. Perbtani, Julia Loeb, Nanlong Liu, Peter V. Draganov, David S. Estores, et al. (+4)
148 [GO] 2021―May―10 109 THE RISK ASSESSMENT OF NASOGASTRIC INTUBATION, A DAILY CLINICAL PRACTICE, DURING THE COVID-19 THREAT BY AEROSOL GENERATION AND DROPLET SPREAD Wout Verbeure, Annelies Geeraerts, I-Hsuan Huang, Lien Timmermans, Joran Toth, Hannelore Geysen, et al. (+8)
149 [GO] 2021―May―10 163 EPIDEMIOLOGY OF PEDIATRIC FOREIGN BODY INGESTIONS AMIDST THE CORONAVIRUS 2019 PANDEMIC AT A SINGLE TERTIARY CARE CHILDREN'S HOSPITAL Katherine Black, Lauren J. Klein, Michael Dole, Danielle K. Orsagh-Yentis
150 [GO] 2021―Apr―29 COVID-19: Guidance for What Clinicians and Scientists Should Do and When Douglas A. Corley, Richard M. Peek
151 [GO] 2021―Apr―20 Reply to the Editor's letter: Tacrolimus use and COVID-19 infection in patients after solid organ transplantation Luca S. Belli, Sara Conti, Wojciech Polak
152 [GO] 2021―Apr―20 Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies Serre-Yu Wong, Rebekah Dixon, Vicky Martinez Pazos, Sacha Gnjatic, Jean-Frederic Colombel, Ken Cadwell, et al. (+36)
153 [GO] 2021―Apr―16 Non-invasive Colorectal Cancer Screening Tests Help Close Screening Gaps during COVID-19 Pandemic Anthony Myint, Lily Roh, Liu Yang, Lynn Connolly, Eric Esrailian, Folasade P. May
154 [GO] 2021―Mar―31 Elevated liver enzymes, ferritin, CRP, D-dimer, and age are predictive markers of outcomes among Covid-19 African Americans and Hispanic patients Hassan Ashktorab, Antonio Pizuorno, Farshad Aduli, Adeyinka O. Laiyemo, Gholamreza Oskrochi, Hassan Brim
155 [GO] 2021―Mar―19 COVID-19 gastrointestinal symptoms and attenuation of the immune response to SARS-CoV-2 Jonathan Miller, Kelley S. Yan
156 [GO] 2021―Mar―09 The associations between pharmacological gastric acid suppression and adverse outcomes in patients with COVID-19 Cong Dai, Min Jiang, Yu-hong Huang
157 [GO] 2021―Mar―04 Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms Alexandra E. Livanos, Divya Jha, Francesca Cossarini, Ana S. Gonzalez-Reiche, Minami Tokuyama, Teresa Aydillo, et al. (+47)
158 [GO] 2021―Mar―04 Changes to Pediatric Gastroenterology Practice during the COVID-19 Pandemic and Lessons Learned: An International Survey of Division and Group Heads Sharon S. Tam, Joseph A. Picoraro, Sandeep K. Gupta, Salvatore Oliva, Raoul I. Furlano, Catharine M. Walsh, et al. (+3)
159 [GO] 2021―Mar―01 Impact of COVID-19 Pandemic on Gastrointestinal Procedures and Cancers in the United States. A Multicenter Research Network Study. Ahmad Khan, Mohammad Bilal, Vincent Morrow, Gregory Cooper, Shyam Thakkar, Shailendra Singh, et al. (+3)
160 [GO] 2021―Feb―27 The rs738409 G allele in PNPLA3 is associated with a reduced risk of COVID-19 mortality and hospitalisation. Hamish Innes, Stephan Buch, Eleanor Barnes, Jochen Hampe, Thomas Marjot, Felix Stickel
161 [GO] 2021―Feb―21 Association Between Collagenous and Lymphocytic Colitis and Risk of Severe COVID-19 Hamed Khalili, Tenghao Zheng, Jonas Söderling, Emma Larsson, Mauro D'Amato, Jonas F. Ludvigsson
162 [GO] 2021―Feb―17 Lack of consistent associations between pharmacological gastric acid suppression and adverse outcomes in patients with COVID-19: meta-analysis of observational studies. Faisal Kamal, Muhammad Ali Khan, Sachit Sharma, Zaid Imam, Colin W. Howden
163 [GO] 2021―Feb―07 REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020) Russell D. Cohen, Joseph D. Feuerstein, David T. Rubin
164 [GO] 2021―Feb―05 PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC Randi Opheim, Kristian Moum, Bjørn Moum
165 [GO] 2021―Feb―05 A POPULATION-BASED APPROACH TO DIGITAL OUTREACH, TRIAGE, AND MONITORING OF IBD PATIENTS DURING THE COVID-19 PANDEMIC Ashish Atreja, Farah Fasihuddin, Shashank Garge, Liana Davidoff, Jonathan Rubin, Sarthak Kakkar, et al. (+6)
166 [GO] 2021―Feb―05 TELEMEDICINE IN IBD: GOOD TRUST FROM OUTPATIENTS DURING THE COVID-19 PANDEMIC IN MILAN (LOMBARDY) Andrea Costantino, Daniele Noviello, Stefano Mazza, Roberto Berté, Maurizio Vecchi, Flavio Caprioli
167 [GO] 2021―Feb―05 RISK OF ADVERSE OUTCOMES IN HOSPITALIZED PATIENTS WITH AUTOIMMUNE DISEASE AND COVID-19: A MATCHED COHORT STUDY FROM NEW YORK CITY Adam Faye, Kate Lee, Monika Laszkowska, Judith Kim, John Blackett, Anna McKenney, et al. (+8)
168 [GO] 2021―Feb―05 SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS Wenly Ruan, Faith Ihekweazu, Seema Walsh, Lina Karam, Allyson Wyatt, Huyen Nguyen, Richard Kellermayer
169 [GO] 2021―Feb―05 INCREASED CATHEPSIN EXPRESSION CORRELATES WITH SARS-COV-2 INFECTION IN HUMAN IBD ENTEROIDS David Alvarado, Maria Gomez Castro, Naomi Sonnek, Xueyang Cui, Siyuan Ding, Matthew Ciorba
170 [GO] 2021―Feb―04 Physician-patient communication is key to improve IBD management during COVID-19 pandemic Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese
171 [GO] 2021―Feb―04 SARS-CoV-2 entry molecules’ expression and COVID-19 in inflammatory bowel disease: is the gut critical? Jan Krzysztof Nowak, Rahul Kalla, Jack Satsangi
172 [GO] 2021―Feb―01 Tacrolimus use and COVID-19 infection in patients after solid organ transplantation Saifu Yin, Xianding Wang, Turun Song
173 [GO] 2021―Jan―29 Steering a course through the COVID-19 pandemic: should the SECURE-IBD registry influence prescribing for patients with IBD? Catarina Frias Gomes, Thomas Chapman, Jack Satsangi, Joana Torres
174 [GO] 2021―Jan―26 The Impact of the COVID-19 Pandemic on Barrett’s Esophagus and Esophago-gastric Cancer Richard C. Turkington, Anita Lavery, David Donnelly, Victoria Cairnduff, Damian T. McManus, Helen G. Coleman
175 [GO] 2021―Jan―21 Reply: The New Foe and Old Friends: Are We Ready for Microbiota-based Therapeutics in Treating COVID-19 Patients? Tao Zuo, Yun Kit Yeoh, Siew C. Ng
176 [GO] 2021―Jan―21 Reply: Dysbiosis in SARS-CoV-2 infected patients Zhilu Xu, Francis KL. Chan, Siew C. Ng
177 [GO] 2021―Jan―20 Tropism of SARS-CoV-2 for Barrett’s Esophagus may Increase Susceptibility to Developing COVID-19 Ramon U. Jin, Jeffrey W. Brown, Qing Kay Li, Peter O. Bayguinov, Jean S. Wang, Jason C. Mills, et al. (+3)
178 [GO] 2021―Jan―17 Characteristics of Liver transplant patients infected with COVID-19. Parbatraj Regmi, Fei Liu, Fu-Yu Li
179 [GO] 2021―Jan―14 Gastrointestinal Symptoms Prevalent in Both Children with MIS-C and those with COVID-19 Jonathan Miller, Mercedes Martinez, Kara Margolis
180 [GO] 2021―Jan―14 COVID-19, ACEI/ARBs and gastrointestinal symptoms: Author’s reply Yun Qiu, Nian-Di Tan, Ren Mao
181 [GO] 2021―Jan―14 Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients with Inflammatory Bowel Diseases: Results from an International Registry Erica J. Brenner, Ryan C. Ungaro, Jean-Frederic Colombel, Michael D. Kappelman
182 [GO] 2021―Jan―14 Reply to “The Dilemma in the Management of GI Bleeding During the COVID-19 Pandemic Judith Kim, John B. Doyle, Benjamin Lebwohl
183 [GO] 2021―Jan―14 Famotidine and COVID-19: Author Reply Daniel E. Freedberg, Timothy C. Wang, Julian A. Abrams
184 [GO] 2021―Jan―14 Reply to Letter to the Editor: What is the incidence of COVID-19 in patients with IBD in western countries? John Gubatan, Sidhartha R. Sinha, Aida Habtezion
185 [GO] 2021―Jan―14 Response to the Letters to the Editor: COVID-19 in Patients With Pre-Existing Liver Disease. Shailendra Singh, Ahmad Khan
186 [GO] 2021―Jan―14 Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study Nabeel Khan, Yu-Xiao Yang
187 [GO] 2021―Jan―10 Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Non-Completion in the VHA Cohort During the COVID-19 Pandemic Nadim Mahmud, David E. Kaplan, David S. Goldberg, Tamar H. Taddei, Marina Serper
188 [GO] 2021―Jan―08 SARS-CoV-2 infection in the gastrointestinal tract: fecal-oral route of transmission for COVID-19? X.I.A.N.G.-J.I.N. MENG, T.J.A.K.E. LIANG
189 [GO] 2021―Jan―07 COVID-19 pediatric patients: Gastrointestinal symptoms, presentations, and disparities by race/ethnicity in a large, multi-center United States study Yusuf Ashktorab, Anas Brim, Antonio Pizuorno, Vijay Gayam, Sahar Nikdel, Hassan Brim
190 [GO] 2021―Jan―05 COVID-19 Among Liver Transplant Recipients Dimitrios Moris
191 [GO] 2021―Jan―05 Letter to the Editor: Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients. Alfredo Papa, Antonio Gasbarrini, Loris Riccardo Lopetuso
192 [GO] 2020―Dec―31 Letter to the editor: Famotidine and mortality in COVID-19 Rahul Sethia, Manya Prasad, Pramod Kumar Garg
193 [GO] 2020―Dec―30 Tacrolimus: Unlikely harmful and perhaps helpful in liver transplant recipients with COVID-19 Meredith M. Pearson, Ajit P. Limaye, Scott W. Biggins
194 [GO] 2020―Dec―30 Famotidine and COVID-19 Daniel E. Freedberg, Timothy C. Wang, Julian A. Abrams
195 [GO] 2020―Dec―30 COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions Ryan C. Ungaro, Michael D. Kappelman, David T. Rubin, Jean-Frederic Colombel
196 [GO] 2020―Dec―30 Dysbiosis in SARS-CoV-2 infected patients Massimiliano Marazzato, Giancarlo Ceccarelli
197 [GO] 2020―Dec―30 Correlation between liver function tests abnormalities and interleukin-6 serum levels in patients with SARS-CoV-2 infection Ponziani Francesca Romana, Nesci Antonio, Del Zompo Fabio, Santopaolo Francesco, Pompili Maurizio, Gasbarrini Antonio
198 [GO] 2020―Dec―16 Potential Biases in Studies of Acid Suppressing Drugs and COVID-19 Infection Mahyar Etminan, Maryam Nazemipour, Mohit Sodhi, Mohammad Ali Mansournia
199 [GO] 2020―Dec―09 Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study. Luca S. Belli, Constantino Fondevila, Paolo A. Cortesi, Sara Conti, Vincent Karam, Rene Adam, et al. (+27)
200 [GO] 2020―Dec―09 The gastrointestinal tract is an alternative route for SARS-CoV-2 infection in a nonhuman primate model Li Jiao, Haiyan Li, Jingwen Xu, Mengli Yang, Chunxia Ma, Jingmei Li, et al. (+16)
201 [GO] 2020―Dec―07 Estimating the backlog of colonoscopy due to COVID-19 and comparing strategies to recover in Ontario, Canada Jill Tinmouth, Steven Dong, Christine Stogios, Linda Rabeneck, Michelle Rey, Catherine Dubé
202 [GO] 2020―Nov―24 AGA Institute Quality Measure Development for the Diagnosis and Management of COVID-19 David A. Leiman, Jennifer K. Maratt, Gyanprakash A. Ketwaroo
203 [GO] 2020―Nov―20 Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities with Chronic Liver Diseases (CLD) Nia Adeniji, Rotonya M. Carr, Elizabeth S. Aby, Andreea M. Catana, Kara Wegermann, Renumathy Dhanasekaran
204 [GO] 2020―Nov―20 Can COVID-19 trigger de novo inflammatory bowel disease? Carlos Taxonera, Joaquín Fisac, Cristina Alba
205 [GO] 2020―Nov―12 Association between pre-admission acid suppressive medication exposure and severity of illness in patients hospitalized with COVID-19 B. Joseph Elmunzer, Bethany J. Wolf, James M. Scheiman, William M. Tierney, Jason R. Taylor
206 [GO] 2020―Nov―12 Low incidence of severe gastrointestinal complications in COVID-19 patients admitted to the intensive care unit: a large, multi-center study Emad Qayed, Amar R. Deshpande, B. Joseph Elmunzer
207 [GO] 2020―Nov―06 COVID-19 in Latin America: Symptoms, Morbidities and Gastrointestinal Manifestations Hassan Ashktorab, Antonio Pizuorno, Gholamreza Oskroch, Nora Alma Fierro González, Zaki A. Sherif, Hassan Brim
208 [GO] 2020―Oct―31 The Role of Angiotensin Converting Enzyme 2 (ACE2) in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection Josef M. Penninger, Maria B. Grant, Joseph J.Y. Sung
209 [GO] 2020―Oct―28 Hyperlipasemia and potential pancreatic injury patterns in COVID-19: A marker of severity or innocent bystander? Hemant Goyal, Sonali Sachdeva, Abhilash Perisetti, Rupinder Mann, Sumant Inamdar, Benjamin Tharian
210 [GO] 2020―Oct―22 Reduction of IBD healthcare during the COVID-19 pandemic: a nationwide retrospective cohort study Maarten te Groen, Monica E.W. Derks, Chantal C.H.J. Kuijpers, Iris D. Nagtegaal, Frank Hoentjen
211 [GO] 2020―Oct―21 Cancer Screening during COVID-19: A Perspective from NCI’s PROSPR consortium Douglas A. Corley, Mai Sedki, Debra P. Ritzwoller, Robert T. Greenlee, Christine Neslund-Dudas, Katharine A. Rendle, et al. (+7)
212 [GO] 2020―Oct―17 The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn’s disease and regulated by microbial and inflammatory signaling Jay Vasant Patankar, Mircea Chiriac, Malte Lehmann, Anja A. Kühl, Raja Atreya, Christoph Becker
213 [GO] 2020―Oct―14 Winter is coming! Clinical, immunological, and practical considerations for vaccinating patients with IBD during the COVID pandemic Gil Y. Melmed, David T. Rubin, Dermot P.B. McGovern
214 [GO] 2020―Oct―12 Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized COVID-19 Patients from a Large Healthcare System Samrat Yeramaneni, Pratik Doshi, Kenneth Sands, Mandelin Cooper, Dax Kurbegov, Gregg Fromell
215 [GO] 2020―Oct―08 COVID-19 and Jaundice Michael Weaver, Scott McHenry, Koushik Das
216 [GO] 2020―Oct―04 ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein Qin Zhang, Dennis K. Jeppesen, James N. Higginbotham, Jeffrey L. Franklin, James E. Crowe, Robert J. Coffey
217 [GO] 2020―Sep―30 Clinical Characteristics, Hospitalization and Mortality Rates of COVID-19 Among Liver Transplant Patients in the United States: A Multi-Center Research Network Study Emad Mansoor, Abe Perez, Mohannad Abou-Saleh, Seth N. Sclair, Stanley Cohen, Gregory S. Cooper, et al. (+3)
218 [GO] 2020―Sep―25 Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease Mayte Suárez-Fariñas, Minami Tokuyama, Gabrielle Wei, Ruiqi Huang, Alexandra Livanos, Divya Jha, et al. (+32)
219 [GO] 2020―Sep―24 Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score Matched Study using UK Biobank Acid Suppressants and the Risk of COVID-19 Xiude Fan, Zhengwen Liu, Tatsunori Miyata, Srinivasan Dasarathy, Daniel M. Rotroff, Laura E. Nagy, et al. (+2)
220 [GO] 2020―Sep―20 Colorectal cancer screening in the COVID-19 era Evelien Dekker, Han-Mo Chiu, Iris Lansdorp-Vogelaar, Luis Ernesto Caro, Jason A. Dominitz, Stephen Halloran, et al. (+17)
221 [GO] 2020―Sep―16 INTESTINAL MICROBIOME MODULATION DURING COVID-19: ANOTHER CHANCE TO MANAGE THE DISEASE? Antonio TURSI, Alfredo PAPA
222 [GO] 2020―Sep―16 Obesity and mortality in COVID-19: cause or association? Abhinav Anand, Ramesh Kumar
223 [GO] 2020―Aug―30 The New Foe and Old Friends: Are We Ready for Microbiota-based Therapeutics in Treating COVID-19 Patients? Ye Peng, Jincun Zhao, Hein M. Tun
224 [GO] 2020―Aug―30 Should IBD Patients Be Tested for Active COVID-19 Prior Starting a Biological Treatment? Brigida Barberio, Andrea Buda, Edoardo Vincenzo Savarino
225 [GO] 2020―Aug―26 Prevalence, risk factors, and outcomes of hospitalized patients with COVID-19 presenting as acute pancreatitis Sumant Inamdar, Petros C. Benias, Yan Liu, Divyesh V. Sejpal, Sanjaya K. Satapathy, Arvind J. Trindade
226 [GO] 2020―Aug―26 Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment Lorenzo Norsa, Paola Cosimo, Amedeo Indriolo, Naire Sansotta, Lorenzo D’Antiga, Annapaola Callegaro
227 [GO] 2020―Aug―21 Impact of Obesity on Outcomes of Patients with COVID-19 in United States: A Multicenter Electronic Health Records Network Study. Shailendra Singh, Mohammad Bilal, Haig Pakhchanian, Rahul Raiker, Gursimran S. Kochhar, Christopher C. Thompson
228 [GO] 2020―Aug―18 CME Exam 1: Corticosteroids, But Not TNF Antagonists, Are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
229 [GO] 2020―Aug―07 What underlies the benefit of famotidine formulations used during COVID-19? Vijay P. Singh, Bara El-Kurdi, Christopher Rood
230 [GO] 2020―Jul―28 AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV2 Testing and Endoscopy Shahnaz Sultan, Shazia M. Siddique, Osama Altayar, Angela M. Caliendo, Perica Davitkov, Joseph D. Feuerstein, et al. (+5)
231 [GO] 2020―Jul―25 Clinical Outcomes of Acute Pancreatitis in Patients with COVID-19 Ahmed Dirweesh, Yiting Li, Guru Trikudanathan, J. Shawn Mallery, Martin L. Freeman, Stuart K. Amateau
232 [GO] 2020―Jul―25 Collateral Effect of COVID-19 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases - A Territory-wide Observational Study in Hong Kong Louis HS. Lau, Sunny H. Wong, Terry CF. Yip, Grace LH. Wong, Vincent WS. Wong, Joseph JY. Sung
233 [GO] 2020―Jul―22 The impact of the COVID-19 pandemic on access to endoscopy procedures in the VA healthcare system Andrew J. Gawron, Tonya Kaltenbach, Jason A. Dominitz
234 [GO] 2020―Jul―17 Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19 Péter Hegyi, Zsolt Szakács, Miklós Sahin-Tóth
235 [GO] 2020―Jul―17 What is the incidence of COVID-19 in patients with IBD in western countries? Carlos Taxonera, Cristina Alba, David Olivares
236 [GO] 2020―Jul―17 The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem? Brigida Barberio, Fabiana Zingone, Lorenzo Bertani, Edoardo Savarino
237 [GO] 2020―Jul―16 COVID-19, ACEI/ARBs and gastrointestinal symptoms: the jury is still out on the association. Tommaso Lorenzo Parigi, Edoardo Vespa, Nicola Pugliese
238 [GO] 2020―Jul―16 Acute on Chronic Liver Failure - Possibly the main culprit of increased mortality in COVID-19 patients with liver disease Muhammad Umair Khan, Kamran Mushtaq, Saad Rashid Alkaabi
239 [GO] 2020―Jul―16 Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study Ka Shing Cheung, Ivan FN. Hung, Wai K. Leung
240 [GO] 2020―Jul―16 Outcomes of universal pre-procedure COVID-19 testing prior to endoscopy in a tertiary care center in New York City Michael T. Dolinger, Nikhil A. Kumta, David A. Greenwald, Marla C. Dubinsky
241 [GO] 2020―Jul―16 Screening and surveillance colonoscopy and COVID-19: avoiding more casualties Samir Gupta, David Lieberman
242 [GO] 2020―Jul―07 The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry Maria Cappello, Anita Busacca, Laura Guida
243 [GO] 2020―Jul―01 THE COURAGE TO RETURN TO EVERYDAY LIFE AT THE TIME OF COVID-19: THE POINT OF VIEW OF INFLAMMATORY BOWEL DISEASE PATIENTS NEEDING ENDOSCOPY. Filippo Mocciaro, Daniela Scimeca, Roberto Di Mitri
244 [GO] 2020―Jun―26 Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge Tao Zuo, Hui Zhan, Fen Zhang, Qin Liu, Eugene Y.K. Tso, Grace C.Y. Lui, et al. (+6)
245 [GO] 2020―Jun―23 Spotlight: COVID-19 PPE and Endoscopy Shazia M. Siddique, Shahnaz Sultan, Joseph K. Lim, Osama Altayar, Perica Davitkov, Joseph D. Feuerstein, et al. (+2)
246 [GO] 2020―Jun―20 Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study Nabeel Khan, Dhruvan Patel, Dawei Xie, Tyler Pernes, James Lewis, Yu-Xiao Yang
247 [GO] 2020―Jun―20 TeleHealth utilization in Gastroenterology (GI) clinics amid Coronavirus-19 (COVID-19) pandemic: Impact on clinical practice & GI training Tara Keihanian, Prateek Sharma, Jatinder Goyal, Daniel A. Sussman, Mohit Girotra
248 [GO] 2020―Jun―18 Positive Early Patient and Clinician Experience with Telemedicine in an Academic Gastroenterology Practice during the COVID-19 Pandemic Marina Serper, Frederick Nunes, Nuzhat Ahmad, Divya Roberts, David C. Metz, Shivan J. Mehta
249 [GO] 2020―Jun―18 COVID-19 transmission among gastrointestinal endoscopists Maximilien Barret, Olivier Gronier, Stanislas Chaussade
250 [GO] 2020―Jun―17 Implementation and Impact of Universal Pre-procedure Testing of Patients for COVID-19 prior to Endoscopy Alexander Podboy, George Cholankeril, Lisa Cianfichi, Edward Guzman, Aijaz Ahmed, Subhas Banerjee
251 [GO] 2020―Jun―16 Impact of Pre-existing Chronic Liver Disease on the Outcome of Patients with COVID-19 Disease Nipun Verma, Ajay Duseja, Virendra Singh
252 [GO] 2020―Jun―16 The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom Keith Siau, Marietta Iacucci, Paul Dunckley, Ian Penman
253 [GO] 2020―Jun―16 Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak Junrong Chen, Xiang Peng, Min Zhang, Min Zhi
254 [GO] 2020―Jun―16 SEVERE IBD FLARES AND COVID-19: EXPAND THE GASTROENTEROLOGY-SURGERY TEAM TO INCLUDE AN INFECTIOUS DISEASE SPECIALIST Cristina Bezzio, Simone Saibeni
255 [GO] 2020―Jun―16 Aminosalicylates and COVID-19: Facts or Coincidences? Fernando Magro, Claudia Camila Dias, Manuela Morato
256 [GO] 2020―Jun―16 TNFα-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease Amber Bangma, Michiel Dirk Voskuil, Rinse K. Weersma
257 [GO] 2020―Jun―16 Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic Oliver Brain, Jack Satsangi
258 [GO] 2020―Jun―13 COVID-19 and Future Implications for Gastroenterology Trainees Lady Katherine Mejía Pérez, Neel Sharma
259 [GO] 2020―Jun―13 The Dilemma in the Management of GI Bleeding During the COVID-19 Pandemic Enrik John T. Aguila, Ian Homer Y. Cua, Nikko Theodore V. Raymundo
260 [GO] 2020―Jun―13 Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous with Injury or Noise? Aditya Ashok, Mayha Faghih, Vikesh K. Singh
261 [GO] 2020―Jun―13 SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance Xiao-Cun Xing, Bei Qi, Kai Deng
262 [GO] 2020―Jun―12 Covid-19 Has Come Home to Roost in Gastroenterology Christopher Koh, T. Jake Liang
263 [GO] 2020―Jun―11 Global Impact of the COVID-19 Pandemic on Endoscopy: An International Survey of 252 Centers from 55 Countries Sravanthi Parasa, Nageshwar Reddy, Douglas O. Faigel, Alessandro Repici, Fabian Emura, Prateek Sharma
264 [GO] 2020―Jun―06 Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study. Shailendra Singh, Ahmad Khan, Monica Chowdhry, Mohammad Bilal, Gursimran S. Kochhar, Kofi Clarke
265 [GO] 2020―Jun―04 Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases Jonathan Miller, Amanda Cantor, Philip Zachariah, Danielle Ahn, Mercedes Martinez, Kara Margolis
266 [GO] 2020―Jun―01 Emerging phenotype of SARS-CoV2 associated pancreatitis. Peter Szatmary, Ankur Arora, Michael Godwin Thomas Raraty, Declan Francis Joseph Dunne, Ryan David Baron, Christopher Michael Halloran
267 [GO] 2020―May―30 Changes in Pediatric Endoscopic Practice during the COVID-19 Pandemic: Results from an International Survey Wenly Ruan, Douglas S. Fishman, Diana G. Lerner, Melinda A. Engevik, B. Joseph Elmunzer, Catharine M. Walsh
268 [GO] 2020―May―29 Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease Dana J. Lukin, Anand Kumar, Kaveh Hajifathalian, Reem Z. Sharaiha, Ellen J. Scherl, Randy S. Longman
269 [GO] 2020―May―29 Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study Nabeel Khan, Dhruvan Patel, Dawei Xie, James Lewis, Chinmay Trivedi, Yu-Xiao Yang
270 [GO] 2020―May―29 Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease Charlie W. Lees, Miguel Regueiro, Uma Mahadevan
271 [GO] 2020―May―27 MORTALITY FROM COVID-19 INCREASES WITH UNSATURATED FAT, AND MAY BE REDUCED BY EARLY CALCIUM AND ALBUMIN SUPPLEMENTATION Bara El-Kurdi, Biswajit Khatua, Christopher Rood, Christine Snozek, Rodrigo Cartin-Ceba, Vijay P. Singh, et al. (+8)
272 [GO] 2020―May―26 Yield and Implications of Pre-Procedural COVID-19 PCR Testing on Routine Endoscopic Practice Justin J. Forde, David Goldberg, Daniel Sussman, Frederick Soriano, Jodie A. Barkin, Sunil Amin
273 [GO] 2020―May―23 Positive FIT or Cologuard in the Era of COVID-19 Pandemic Sheena Mago, Patrick E. Young, Micheal Tadros
274 [GO] 2020―May―22 Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study Daniel E. Freedberg, Joseph Conigliaro, Timothy C. Wang, Kevin J. Tracey, Michael V. Callahan, Julian A. Abrams, et al. (+9)
275 [GO] 2020―May―21 Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico). Jose María Remes-Troche;, Antonio Ramos-de-la-Medina;, Marisol Manríquez-Reyes;, Laura Martínez-Pérez-Maldonado;, Elizabeth Lagunes Lara;, María Antonieta Solís-González.
276 [GO] 2020―May―20 Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization Tao Zuo, Fen Zhang, Grace C.Y. Lui, Yun Kit Yeoh, Amy Y.L. Li, Hui Zhan, et al. (+15)
277 [GO] 2020―May―20 COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter Brian T. Lee, Ponni V. Perumalswami, Gene Y. Im, Sander Florman, Thomas D. Schiano
278 [GO] 2020―May―18 Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19 Shubha Bhat, Francis A. Farraye, Alan Moss
279 [GO] 2020―May―18 Focusing on gastrointestinal symptoms in COVID-19 is far from enough Yuzhi Liu, Lingya Xiang, Kai Deng
280 [GO] 2020―May―18 Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry Erica J. Brenner, Ryan C. Ungaro, Richard B. Gearry, Gilaad G. Kaplan, Michele Kissous-Hunt, James D. Lewis, et al. (+9)
281 [GO] 2020―May―18 The utility of fecal calprotectin in the era of COVID-19 pandemic
282 [GO] 2020―May―18 Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic Vivek Kaul, Vijay H. Shah, Hashem El-Serag
283 [GO] 2020―May―18 COVID-19: Long-term Planning for Procedure-based Specialties During Extended Mitigation and Suppression Strategies Smita Rouillard, Vincent X. Liu, Douglas A. Corley
284 [GO] 2020―May―17 Impacts of COVID-19 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-based Study Thomas KL. Lui, Kathy Leung, Chuan-Guo Guo, Vivien WM. Tsui, Joseph T. Wu, Wai K. Leung
285 [GO] 2020―May―16 Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19 Nian-Di Tan, Yun Qiu, Xiang-Bin Xing, Subrata Ghosh, Min-Hu Chen, Ren Mao
286 [GO] 2020―May―16 Endoscopy staff are concerned about acquiring COVID-19 infection when resuming elective endoscopy Douglas K. Rex, Krishna C. Vemulapalli, Rachel E. Lahr, Lee McHenry, Stuart Sherman, Mohammad Al-Haddad
287 [GO] 2020―May―16 Are Gastrointestinal Symptoms Specific for COVID-19 Infection? A Prospective Case-Control Study from the United States Alan Chen, Amol Agarwal, Nishal Ravindran, Chau To, Talan Zhang, Paul J. Thuluvath
288 [GO] 2020―May―16 Most Patients Are Willing to Undergo Elective Endoscopic Procedures During the Reopening Period of the COVID-19 Pandemic Douglas K. Rex, Krishna C. Vemulapalli, Meghan J. Kane, Lee McHenry, Stuart Sherman, Mohammad Al-Haddad
289 [GO] 2020―May―16 The Time Sequences of Oral and Fecal Viral Shedding of Coronavirus Disease 2019 (COVID-19) Patients Fang Zhao, Yang Yang, Zhaoqin Wang, Liang Li, Lei Liu, Yingxia Liu
290 [GO] 2020―May―15 Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic Paulo Gustavo Kotze, Laurent Peyrin-Biroulet, Silvio Danese
291 [GO] 2020―May―13 Effect of the COVID-19 Pandemic on Outcomes for Patients Admitted with Gastrointestinal Bleeding in New York City Judith Kim, John B. Doyle, John W. Blackett, Benjamin May, Chin Hur, Benjamin Lebwohl
292 [GO] 2020―May―12 Impact of COVID-19 outbreak on the management of patients with severe IBD: a domino effect Vincenzo Occhipinti, Simone Saibeni, Gianluca M. Sampietro, Luca Pastorelli
293 [GO] 2020―May―12 Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19? Fabio Salvatore Macaluso, Ambrogio Orlando
294 [GO] 2020―May―12 Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease. Nowak Jan Krzysztof, Lindstrøm Jonas Christoffer, Kalla Rahul, Petr Ricanek, Halfvarson Jonas, Satsangi Jack
295 [GO] 2020―May―11 AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 Shahnaz Sultan, Osama Altayar, Shazia M. Siddique, Perica Davitkov, Joseph D. Feuerstein, Joseph K. Lim, et al. (+2)
296 [GO] 2020―May―11 Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2 Cheng Wang, Shaobo Wang, Daixi Li, Dong-Qing Wei, Jinghong Zhao, Junping Wang
297 [GO] 2020―May―08 Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: A Large Cohort from South America Luis Antonio Díaz, Tamara García-Salum, Eduardo Fuentes-López, Marcela Ferrés, Rafael A. Medina, Arnoldo Riquelme, et al. (+13)
298 [GO] 2020―May―08 Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications. Kaveh Hajifathalian, Tibor Krisko, Amit Mehta, Sonal Kumar, Robert Schwartz, Brett Fortune, et al. (+28)
299 [GO] 2020―May―08 Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste C. Gower-Rousseau, M. Fumery, B. Pariente
300 [GO] 2020―May―07 SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California John Gubatan, Steven Levitte, Tatiana Balabanis, Akshar Patel, Arpita Sharma, Aida Habtezion
301 [GO] 2020―May―07 How To Maximize Trainee Education During the COVID-19 Pandemic: Perspectives from Around the World Rajesh N. Keswani, Amrita Sethi, Alessandro Repici, Helmut Messman, Philip Chiu
302 [GO] 2020―May―06 Striving to protect patients and healthcare professionals in endoscopy units during pandemics: from SARS to COVID-19 Rashid N. Lui, Raymond SY. Tang, Philip WY. Chiu
303 [GO] 2020―May―06 Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study Nadim Mahmud, Rebecca A. Hubbard, David E. Kaplan, Marina Serper
304 [GO] 2020―May―05 Taste Changes (Dysgeusia) in COVID-19: A systematic review and metaanalysis Muhammad Aziz, Abhilash Perisetti, Wade M. Lee-Smith, Mahesh Gajendran, Pardeep Bansal, Hemant Goyal
305 [GO] 2020―May―04 Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study Shailendra Singh, Ahmad Khan
306 [GO] 2020―May―04 Changes in Gastroenterology and Endoscopy Practices in Response to the COVID-19 Pandemic: Results from a North American Survey Nauzer Forbes, Zachary L. Smith, Rebecca L. Spitzer, Rajesh N. Keswani, Sachin B. Wani, B. Joseph Elmunzer
307 [GO] 2020―May―01 German endoscopy unit preparations for the COVID-19 pandemic: A nationwide survey Jakob Garbe, Stephan Eisenmann, Steffen Walter, Frank Lammert, Kaid Darwiche, Jonas Rosendahl
308 [GO] 2020―Apr―30 Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn’s and Colitis Organization (ECCO) Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet, Hart Ailsa, Torsten Kucharzik, Fernando Magro, et al. (+4)
309 [GO] 2020―Apr―27 COVID-19 and ACE2 in the liver and gastrointestinal tract: Putative biological explanations of sexual dimorphism Carlos J. Pirola, Silvia Sookoian
310 [GO] 2020―Apr―27 Letter: Gastrointestinal ACE2, COVID-19 and IBD - opportunity in the face of tragedy? Mayur Garg, Britt Christensen, John S. Lubel
311 [GO] 2020―Apr―27 Lay-off of Endoscopy services for the COVID-19 pandemic: how can we resume the practice of routine cases? Arnaldo Amato, Emanuele Rondonotti, Franco Radaelli
312 [GO] 2020―Apr―27 Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review Siyuan Ding, T. Jake Liang
313 [GO] 2020―Apr―23 Prevalence and Characteristics of Gastrointestinal Symptoms in Patients with SARS-CoV-2 Infection in the United States: A Multicenter Cohort Study Walker D. Redd, Joyce C. Zhou, Kelly E. Hathorn, Thomas R. McCarty, Ahmad Najdat Bazarbashi, Christopher C. Thompson, et al. (+2)
314 [GO] 2020―Apr―22 Increased amylase and lipase in patients with COVID-19 pneumonia: don´t blame the pancreas just yet! Enrique de-Madaria, Keith Siau, Karina Cárdenas-Jaén
315 [GO] 2020―Apr―22 Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain) Iago Rodríguez-Lago, Patricia Ramírez de la Piscina, Ainara Elorza, Olga Merino, Jone Ortiz de Zárate, José Luis Cabriada
316 [GO] 2020―Apr―16 Inflammatory bowel diseases and COVID-19: the invisible enemy Ferdinando D’Amico, Laurent Peyrin-Biroulet, Silvio Danese
317 [GO] 2020―Apr―12 Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States Yael R. Nobel, Meaghan Phipps, Jason Zucker, Benjamin Lebwohl, Timothy C. Wang, Magdalena E. Sobieszczyk, Daniel E. Freedberg
318 [GO] 2020―Apr―10 COVID-19 and the liver: the perils of non-peer reviewed science in times of a pandemic Jose D. Debes
319 [GO] 2020―Apr―10 Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy Alessandro Repici, Fabio Pace, Roberto Gabbiadini, Matteo Colombo, Cesare Hassan, Marco Dinelli, et al. (+48)
320 [GO] 2020―Apr―10 AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary David T. Rubin, Joseph D. Feuerstein, Andrew Y. Wang, Russell D. Cohen
321 [GO] 2020―Apr―10 Why does SARS-CoV-2 invade the gastrointestinal epithelium? Yoshiharu Uno
322 [GO] 2020―Apr―10 High Prevalence of Concurrent Gastrointestinal Manifestations in Patients with SARS-CoV-2: Early Experience from California George Cholankeril, Alexander Podboy, Vasiliki Irene Aivaliotis, Branden Tarlow, Edward A. Pham, Sean Spencer, et al. (+3)
323 [GO] 2020―Apr―06 Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting David T. Rubin, Maria T. Abreu, Victoria Rai, Corey A. Siegel
324 [GO] 2020―Apr―04 Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis Ka Shing Cheung, Ivan FN. Hung, Pierre PY. Chan, K.C. Lung, Eugene Tso, Raymond Liu, et al. (+15)
325 [GO] 2020―Apr―02 Fighting the battle against SARS-CoV-2 as gastroenterologists in Italy Cristiano Pagnini, Riccardo Urgesi, Maria Carla Di Paolo, Maria Giovanna Graziani
326 [GO] 2020―Apr―02 Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy Lorenzo Norsa, Amedeo Indriolo, Naire Sansotta, Paola Cosimo, Salvatore Greco, Lorenzo D'Antiga
327 [GO] 2020―Apr―02 Faecal-oral transmission of SARS-COV-2: practical implications Giulia Bonato, Lorenzo Dioscoridi, Massimiliano Mutignani
328 [GO] 2020―Apr―01 AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic Shahnaz Sultan, Joseph K. Lim, Osama Altayar, Perica Davitkov, Joseph D. Feuerstein, Shazia M. Siddique, et al. (+2)
329 [GO] 2020―Apr―01 Pancreatic injury patterns in patients with COVID-19 pneumonia Fan Wang, Haizhou Wang, Junli Fan, Yongxi Zhang, Hongling Wang, Qiu Zhao
330 [GO] 2020―Mar―28 Multi-omics Evaluation of Gastrointestinal and Other Clinical Characteristics of SARS-CoV-2 and COVID-19 Mulong Du, Guoshuai Cai, Feng Chen, David C. Christiani, Zhengdong Zhang, Meilin Wang
331 [GO] 2020―Mar―27 Responding to COVID-19: Perspectives from the Chinese Society of Gastroenterology Ren Mao, Jie Liang, Kai-Chun Wu, Min-Hu Chen
332 [GO] 2020―Mar―19 Effect of gastrointestinal symptoms on patients infected with COVID-19 Zili Zhou, Ning Zhao, Yan Shu, Shengbo Han, Bin Chen, Xiaogang Shu
333 [GO] 2020―Mar―19 COVID-19: What Should Clinicians and Scientists Do and When? Douglas A. Corley, Richard M. Peek
334 [GO] 2020―Mar―03 COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission Jinyang Gu, Bing Han, Jian Wang
335 [GO] 2020―Mar―03 Evidence for gastrointestinal infection of SARS-CoV-2 Fei Xiao, Meiwen Tang, Xiaobin Zheng, Ye Liu, Xiaofeng Li, Hong Shan


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.121 sec